Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2019
SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic LeukemiaShilpa Paul, Caitlin R Rausch, Mary Alma Welch, et al.
Leukemia & Lymphoma|November 20, 2019
Complexity of chronic-phase CML management after failing a second-generation TKIRiad El Fakih, Naeem Chaudhri, Feras Alfraih, et al.
Leukemia & Lymphoma|July 19, 2017
PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia <sup>†</sup>Caitlin R Rausch, Bernard L Marini, Lydia L Benitez, et al.
Blood Cancer Discovery|November 20, 2024
Venetoclax-Based Combination Regimens in Acute Myeloid LeukemiaHannah Goulart, Hagop Kantarjian, Naveen Pemmaraju, et al.
Leukemia & Lymphoma|June 15, 2023
Incidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulationLaura M Roccograndi, Alexandra R Lovell, Alessandra Ferrajoli, et al.
Cancer|February 10, 2024
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndromeAshley Dinh, J Michael Savoy, Dimitrios P Kontoyiannis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2022
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted TherapiesCaitlin R Rausch, Adam J DiPippo, Ying Jiang, et al.
Leukemia & Lymphoma|October 12, 2022
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungalsKayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell, et al.
Leukemia & Lymphoma|December 6, 2023
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patientsWei-Ying Jen, Koji Sasaki, Caitlin R Rausch, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2020
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaGuillaume Richard-Carpentier, Elias Jabbour, Nicholas J Short, et al.
Pageof 4